Category: Regulatory Affairs

Pharma Regulations in Germany & How Vigilare Supports Seamless Compliance

Germany is Europe’s largest pharma market with strict regulations. Learn how Vigilare helps companies navigate BfArM, EMA, and EU compliance with speed and clarity.

By Vigilare Biopharma October 1, 2025 Medical Devices

Deep Dive: Essential Elements for Clear and Concise Labelling Text for Medical Devices

Medical device labelling is more than just a regulatory requirement—it’s a critical communication tool that ensures safety, usability, and compliance. Whether you’re a manufacturer, distributor, or healthcare provider, understanding the essential elements of clear and

By Vigilare Biopharma June 11, 2025 Regulatory Affairs

PRAC June 2025 Meeting Insights: What It Means & How Vigilare Biopharma Can Help

From Vigilare Biopharma: The recent PRAC meeting (2-5 June 2025) underscores the relentless pace of pharmacovigilance evolution. From gene therapy safety to AI integration and refined risk management for established classes, the demands on sponsors

By Vigilare Biopharma April 29, 2025 Post Marketing

Mastering Post-Approval Changes: Transform Regulatory Hurdles into a Competitive Advantage

The Evolving Pharma Landscape: Innovation Demands AgilityThe pharmaceutical industry is a dynamic ecosystem where innovation never sleeps. From advancements in manufacturing technologies to shifts in formulation strategies, post-approval changes are inevitable. Yet, every modification—whether to

By Vigilare Biopharma March 10, 2025 Clinical Trails

Is Your Clinical Trial Prepared for ICH E6 (R3)? Key Strategies for Compliance and Success

Is your clinical trial ready for ICH E6 (R3)? Discover the key areas to focus on, from risk-based quality management to digital transformation, and ensure compliance with the latest GCP guidelines.

By Vigilare Biopharma February 5, 2025 Compliance

Regulatory Pathways for Medical Devices: EU MDR vs. FDA 510(k)

EU MDR vs. FDA 510(k) Medical device manufacturers aiming for global market access must navigate complex regulatory frameworks to ensure compliance. Two of the most critical regulatory pathways are the European Union Medical Device Regulation

By Vigilare Biopharma December 26, 2024 Artificial Intelligence

Emerging trends are shaping the Pharmacovigilance and Regulatory Affairs domains in 2025

Several Emerging trends are shaping the Pharmacovigilance and Regulatory Affairs domains in 2025 making their collaboration even more critical: 1. Integration of Artificial Intelligence (AI) and Machine Learning (ML) AI and ML are revolutionizing both

Quick Enquiry